Home cancer care breakthrough? new trial lets myeloma patients Self-Inject
Disease control
Recruiting now
This study looks at whether people with relapsed multiple myeloma can safely give themselves the drug elranatamab at home instead of going to a clinic. About 20 participants will be trained to self-inject and will track side effects, time spent, and any unplanned hospital visits.…
Phase: PHASE2 • Sponsor: Thomas Lund • Aim: Disease control
Last updated May 08, 2026 12:03 UTC